Government Grants
Business Grants
Home Owner Programs
Federal Programs
About Us
DoD Breast Cancer, Innovator Award
The Innovator Award supports visionary individuals who have demonstrated exceptional creativity, innovative work, and paradigm-shifting leadership in any field including, but not limited to, breast cancer.
The Innovator Award will provide these individuals with the funding and freedom to pursue
their most novel, visionary, high-risk ideas that could accelerate progress to ending breast cancer.
Because the intent of the Innovator Award mechanism is to recognize these remarkably creative and innovative visionary individuals, rather than projects, the central feature of the award is the innovative contribution that the Principal Investigator (PI) can make toward ending breast cancer.
The PI should have a record of challenging the status quo, shifting paradigms by changing a field of research or approach to patient care, exhibiting high levels of creativity, and demonstrating promise for continued innovation in future work.
These rare individuals will be able to articulate a vision for ending breast cancer that challenges current dogma and demonstrates an ability to look beyond tradition and convention.
The PI is also expected to be established in their field and have demonstrated success at forming and leading effective partnerships and collaborations.
To further the development of innovative individuals and spark the generation of novel ideas, applications are required to incorporate the mentoring of promising junior investigators.
Experience in breast cancer research is not required; however, the application must focus on breast cancer, and the PI must maintain a 50% dedication of their full-time professional effort during the award period to breast cancer research.
This professional effort in breast cancer research can be through a combination of this award and other current support.
Individuals from other disciplines who will apply novel concepts to breast cancer are encouraged to submit.
The PI is expected to assemble a research team that will provide the necessary expertise and collaborative efforts toward accomplishing the research goals.
The PI’s research team must include two or more breast cancer consumer advocates.
As lay representatives, the consumer advocates must be individuals who have been diagnosed with breast cancer and are actively involved in a breast cancer advocacy organization.
Their role should be independent of their employment, and they cannot be employees of any of the organizations participating in the application.
The consumer advocates should have a high level of knowledge of current breast cancer issues and the appropriate background or training in breast cancer research to contribute to the project.
Their role should be focused on providing objective input on the research and its potential impact for individuals with, or at a risk for, breast cancer.
The Innovator Award will provide these individuals with the funding and freedom to pursue
their most novel, visionary, high-risk ideas that could accelerate progress to ending breast cancer.
Because the intent of the Innovator Award mechanism is to recognize these remarkably creative and innovative visionary individuals, rather than projects, the central feature of the award is the innovative contribution that the Principal Investigator (PI) can make toward ending breast cancer.
The PI should have a record of challenging the status quo, shifting paradigms by changing a field of research or approach to patient care, exhibiting high levels of creativity, and demonstrating promise for continued innovation in future work.
These rare individuals will be able to articulate a vision for ending breast cancer that challenges current dogma and demonstrates an ability to look beyond tradition and convention.
The PI is also expected to be established in their field and have demonstrated success at forming and leading effective partnerships and collaborations.
To further the development of innovative individuals and spark the generation of novel ideas, applications are required to incorporate the mentoring of promising junior investigators.
Experience in breast cancer research is not required; however, the application must focus on breast cancer, and the PI must maintain a 50% dedication of their full-time professional effort during the award period to breast cancer research.
This professional effort in breast cancer research can be through a combination of this award and other current support.
Individuals from other disciplines who will apply novel concepts to breast cancer are encouraged to submit.
The PI is expected to assemble a research team that will provide the necessary expertise and collaborative efforts toward accomplishing the research goals.
The PI’s research team must include two or more breast cancer consumer advocates.
As lay representatives, the consumer advocates must be individuals who have been diagnosed with breast cancer and are actively involved in a breast cancer advocacy organization.
Their role should be independent of their employment, and they cannot be employees of any of the organizations participating in the application.
The consumer advocates should have a high level of knowledge of current breast cancer issues and the appropriate background or training in breast cancer research to contribute to the project.
Their role should be focused on providing objective input on the research and its potential impact for individuals with, or at a risk for, breast cancer.
Who's Eligible
Relevant Nonprofit Program Categories
Obtain Full Opportunity Text:
Download Application Package and Instructions using CFDA Number ONLY.
Additional Information of Eligibility:
Colleges and universities that meet the definition of Historically Black Colleges and Universities as determined by the Department of Education in 34 CFR 608.2 in accordance with that Department's responsibilities under Executive Order 13256, dated February 12, 2002.
Applicants must be accredited by a national or regional accrediting agency recognized by the U. S. Department of Education.
If an applicant is one of several campuses of the same institution, the applicant may submit a separate application for each campus.
If applying for funding from separate campuses of the same institution, an applicant must have a DUNS number and use the DUNS + 4 digits to identify the separate campuses from the parent university an administrative and budgeting structure independent of the other campuses in the system, and must meet the definition of an HBCU as outlined above to be eligible to receive HUD grant funds (see the General Section).
Only one application can be submitted per campus.
If multiple applications are submitted from the same campus, all will be disqualified.
Institutions that received an HBCU grant awarded under the HBCU NOFA posted on Grants.gov July 17, 2010 are not eligible to submit an application under this NOFA.
Full Opportunity Web Address:
https://apply07.grants.gov/apply/forms_apps_idx.html
Contact:
Agency Email Description:
CDMRP Help Desk
Agency Email:
Date Posted:
2019-12-23
Application Due Date:
Archive Date:
2020-07-24
Social Entrepreneurship
Spotlight
This Social Innovation Helps Prevent Bed Sores in Wheelchair Users
Co-founders William Mann and David Mravyan devised the Sensimat during a mandatory project for their MBA at the Richard Ivey School of Business in Canada. Sensimat is a device that helps manage and assess pressure among wheelchair users.
Learn How to Identify and Avoid Grant Scams
